Dec 31, 2025 04:03PM LIXT exchanges preferred stock for common shares with Orbit Capital

Dec 23, 2025 08:03AM LIXTE expands ovarian cancer trial to 42 patients

Dec 8, 2025 08:30AM LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities

Dec 3, 2025 11:00AM LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology

Dec 3, 2025 08:07AM LIXTE advances cancer drug LB-100 in combination trials

Dec 3, 2025 08:00AM LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers

Nov 25, 2025 08:32AM LIXTE acquires UK proton therapy company Liora Technologies

Sep 16, 2025 08:30AM LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)

Sep 15, 2025 05:41PM LIXTE Biotechnology announces leadership changes and $5 million funding

Sep 15, 2025 05:40PM LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)

Sep 5, 2025 08:35AM 24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor

Jul 10, 2025 05:05PM Lixte Biotechnology Holdings, Inc. (LIXT) Files for 12.63M Share Offering by Selling Stockholders

Jul 8, 2025 04:05PM Lixte Biotechnology closes $1.5 million registered direct offering

Jul 1, 2025 04:15PM Lixte Biotechnology (LIXT) Announces $5.0 Million Private Placement

Feb 11, 2025 08:44AM Lixte Biotechnology Holdings, Inc. (LIXT) announces $1.05 million direct offering at $2.42 per share

Feb 10, 2025 05:02PM Lixte Biotechnology Holdings, Inc. (LIXT) files to withdraw offering

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Aug 14, 2024 10:50PM Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

Jun 14, 2024 11:01AM LIXTE Biotechnology (LIXT) announces collaboration on a New Colon Cancer Clinical Trial